Skip to Content

435 (Acamprosate Calcium Delayed-Release 333 mg)

Pill with imprint 435 is White, Round and has been identified as Acamprosate Calcium Delayed-Release 333 mg. It is supplied by Glenmark Generics Inc., USA.

Acamprosate is used in the treatment of alcohol dependence and belongs to the drug class drugs used in alcohol dependence. Risk cannot be ruled out during pregnancy. Acamprosate 333 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 435

Acamprosate calcium delayed-release 333 mg 435
Acamprosate calcium delayed-release 333 mg 435  Front
Acamprosate calcium delayed-release 333 mg 435  Back
Acamprosate calcium delayed-release 333 mg 435

Acamprosate Calcium Delayed-Release

Imprint:
435
Strength:
333 mg
Color:
White
Shape:
Round
Availability:
Prescription only
Drug Class:
Drugs used in alcohol dependence
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Glenmark Generics Inc., USA
National Drug Code (NDC):
68462-0435

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide